Luts & Greenleigh Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Luts & Greenleigh Group's AMGN Position: Q2 2026 in Review
Luts & Greenleigh Group opened a new position in Amgen (AMGN) in Q2 2026: 557 shares worth $202K. The stake represents 0.15% of the portfolio and ranks #104 among its holdings. This is a return to the name: Luts & Greenleigh Group previously reported a position in AMGN as recently as Q3 2024.
Luts & Greenleigh Group first reported a position in AMGN in Q2 2024 and has held it in 3 quarters since. The position peaked at $216K in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Luts & Greenleigh Group held 557 shares of Amgen worth $202K as of Q2 2026.
- Amgen was a new Luts & Greenleigh Group position in Q2 2026.
- Amgen made up 0.15% of Luts & Greenleigh Group's portfolio in Q2 2026, its #104 holding.
- Luts & Greenleigh Group first reported a position in Amgen in Q2 2024 and has held it in 3 quarters since.
- Luts & Greenleigh Group's Amgen position peaked at $216K in Q3 2024.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Luts & Greenleigh Group's 13F filing for Q2 2026, filed 7 Aug 2026.